guthridge-targetingp38-2016.pdf (18.88 MB)
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
journal contribution
posted on 2016-02-08, 00:00 authored by N Lalaoui, K Hänggi, G Brumatti, D Chau, N Y N Nguyen, L Vasilikos, L M Spilgies, D A Heckmann, C Ma, M Ghisi, J M Salmon, G M Matthews, E de Valle, D M Moujalled, M B Menon, S K Spall, S P Glaser, J Richmond, R B Lock, S M Condon, R Gugasyan, M Gaestel, Mark GuthridgeMark Guthridge, R W Johnstone, L Munoz, A Wei, P G Ekert, D L Vaux, W W L Wong, J SilkeTargeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
History
Journal
Cancer CellVolume
29Issue
2Pagination
145 - 158Publisher
CELL PRESSLocation
United StatesPublisher DOI
Link to full text
ISSN
1535-6108eISSN
1878-3686Language
EnglishPublication classification
C1.1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC